10 May 10 QRxPharma reports successful outcome of Phase 1 trial for MoxDuo CR for chronic pain
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the …
See original here:
QRxPharma reports successful outcome of Phase 1 trial for MoxDuo CR for chronic pain
Tags: and-neuropathic, determine-which, from-moderate, severe-chronic, successful
03 Feb 10 Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch (Medical News Today)
Phosphagenics Limited (“Phosphagenics”) (ASX: POH; OTCQX: PPGNY) today announced positive results from a Phase 1B clinical study using the Company’s patented TPM™ (Targeted Penetration Matrix) for the transdermal delivery of oxycodone. The results of the successful trial demonstrate that daily application of a TPM™ patch delivers therapeutic levels of oxycodone into the blood stream in a …
Original post:
Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch (Medical News Today)
Tags: into-the-blood, successful, the-successful, today-announced
03 Feb 10 Collegium Pharmaceutical Inc. Presents Scientific Poster for DETERx Tamper-Resistant, Extended Release Technology at … (Business Wire via Yahoo! Finance)
CUMBERLAND, R.I.—-Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced the presentation of a scientific poster summarizing the results of in vitro and pharmacokinetic studies for its tamper-resistant, extended-release oral oxycodone formulation , which is the lead product candidate utilizing the Company’s DETERx™ technology.
Go here to read the rest:
Collegium Pharmaceutical Inc. Presents Scientific Poster for DETERx Tamper-Resistant, Extended Release Technology at … (Business Wire via Yahoo! Finance)
Tags: oral-oxycodone, presentation, results, successful, the-successful
